Helimeds GLP-1 Review (2026) — The $37.25/Week Compounded Tirzepatide With Wegovy + Zepbound Backup, Tested

Helimeds's structural position in the 2026 U.S. telehealth GLP-1 weight-loss category is editorially distinctive in three specific ways: first, the $37.25/week ($149/month) headline price for compounded GLP-1+GIP (tirzepatide) is published upfront — meaningfully cheaper than the typical compounded-tirzepatide tier at platforms like TrimRx ($259/month) or DirectMeds ($399/month) — though above the JRNYS $89 floor. Second, the parallel FDA-approved branded medication paths (Wegovy and Zepbound) on the same platform put Helimeds in the broader-menu category alongside JRNYS and FuturHealth — important structural insurance against future compounded supply tightening. Third, the published peer-reviewed evidence citation (PMC11231910) backing the 15.3% body weight loss claim is editorially commendable; most U.S. telehealth GLP-1 platforms in our review set rely on marketing language rather than specific peer-reviewed source citations. Add full LegitScript approval (verifiable seal 368688), an explicit Travex Inc parent disclosure (sister brand to Clinic Secret), a 5-minute survey intake, free doctor consultation, and 1-on-1 text-only medical support — and Helimeds earns its 4.2/5 rating on substance, not marketing.

Helimeds and Clinic Secret — the Travex Inc relationship

Per the published footer on helimeds.com: "© Copyright 2026, All Rights Reserved by Travex Inc." The same parent owns Clinic Secret. This is editorially material because the two brands target somewhat different value propositions while operating under the same corporate umbrella:

• Clinic Secret emphasizes: 6-month / 12-month tiered money-back weight-loss guarantee; "pure GLP-1 no additives" formula transparency standard; 100,000+ member base; San Antonio TX HQ with published phone; flat-rate pricing across dose escalations; the Pentadeca Arginate (PDA) peptide product line.
• Helimeds emphasizes: $37.25/week headline price; FDA-approved branded Wegovy + Zepbound alongside compounded; peer-reviewed evidence citation (PMC11231910); 5-minute survey; broader adjacent product menu (sermorelin, NAD+, MIC+B12, sexual wellness); 1-on-1 text-only medical support.

If you're cost-comparing within the Travex Inc family, the trade-off is: Clinic Secret for guarantee structure and formula transparency at ~$196/month; Helimeds for $149/month and FDA-approved branded backup. Both display LegitScript certification with verifiable seals.

How Helimeds works (step-by-step)

Helimeds uses a clearly documented 3-step intake process:

1. Complete the 5-minute survey. Share your health history and weight-loss goals via the online intake at helimeds.com. A Helimeds-affiliated provider will review your answers.
2. Get a prescription. If clinically appropriate, your clinician helps select the right dose of a GLP-1 medication (compounded tirzepatide is the headline option; semaglutide, Wegovy, and Zepbound also available) to reach your weight-loss goal.
3. Start your journey. Receive regularly scheduled medication to your door straight from the pharmacy. 1-on-1 text-only medical support throughout.

Helimeds pricing in 2026

Helimeds publishes a headline starting price of $37.25/week — approximately $149/month — for compounded GLP-1+GIP (compounded tirzepatide). A SEMAFIRST100 first-time semaglutide promo is also published. Here's how that positions Helimeds in our 14-platform 2026 review set:

What the $37.25/week actually unlocks

Helimeds's $37.25/week monthly equivalent ($149/month) is editorially competitive specifically because most platforms in our review set price compounded tirzepatide meaningfully higher than compounded semaglutide. TrimRx publishes $179/month semaglutide and $259/month tirzepatide; DirectMeds publishes $179 semaglutide and $399 tirzepatide. Helimeds's $149/month tirzepatide-equivalent headline is a real value proposition for tirzepatide-specifically buyers — provided the entry tier dose meets your clinical needs. The FDA-approved branded Wegovy and Zepbound prices are typically retail cash-pay equivalent ($1,000-$1,400/month range without insurance), with insurance navigation an option for the branded path.

The Helimeds 15.3% weight loss claim — and why the citation matters

Helimeds publishes: "Revolutionary medication helps you lose up to 15% weight in 1 year! According to a real-world observational study of adults with overweight or obesity, individuals treated with GLP1+GIP experienced greater weight loss compared to those on GLP-1. At 12 months, the average weight loss was 15.3% with GLP-1+GIP and 8.3% with GLP-1 agonists. Individual results may vary. Treatment suitability is determined by licensed healthcare providers. Compounded medications are not FDA-approved or evaluated by the FDA for safety, efficacy, or quality. Medication prescriptions are based on medical recommendations from licensed healthcare providers."

The cited source is a real, peer-reviewed publication accessible at PubMed Central PMC11231910. This evidence-citation framing is editorially commendable for three reasons:

1. The source is publicly verifiable. Buyers can read the cited study before purchase — most platforms don't make their evidence base this accessible.
2. Helimeds explicitly notes the FDA-approval distinction within the same disclosure. The "compounded medications are not FDA-approved or evaluated by the FDA for safety, efficacy, or quality" disclaimer is appropriate and transparent.
3. The 15.3% vs 8.3% differential framing aligns with the published GLP-1+GIP vs GLP-1 mechanism rationale — and is consistent with the SURPASS clinical trial program findings supporting tirzepatide's FDA approval.

Medications Helimeds offers

Helimeds offers one of the broader product menus in our 14-platform 2026 review set, spanning weight loss, energy & mood, and sexual wellness:

Weight Loss:

• Compounded GLP-1 (semaglutide) — Compounded GLP-1 Online Prescription
• Compounded Tirzepatide (GLP-1+GIP) — headline $37.25/week entry tier
• Wegovy® (FDA-approved branded semaglutide) — FDA-approved for chronic weight management
• Zepbound® (FDA-approved branded tirzepatide) — FDA-approved for chronic weight management

Energy + Mood:

• Sermorelin — growth hormone secretagogue peptide
• Compounded NAD+
• MIC+B12 lipo shots — Methionine, Inositol, Choline + Vitamin B12

Sexual Health:

• Sildenafil (men's sexual wellness)
• Tadalafil (men's sexual wellness)
• Scream Cream (women's sexual wellness)

For buyers who want a single-platform telehealth account covering multiple categories, Helimeds's breadth is editorially useful — comparable to JRNYS, which also offers a Sexual Wellness category alongside Weight Loss.

Are Helimeds medications compounded or FDA-approved?

Helimeds offers both. The compounded semaglutide and tirzepatide options are not FDA-approved as finished drug products (a category-wide caveat applies). The branded medications — Wegovy (FDA-approved for chronic weight management) and Zepbound (FDA-approved for chronic weight management) — are FDA-reviewed finished drug products with complete FDA-approved labeling.

This both-paths structure is the strongest available insurance against future compounded supply tightening — same structural advantage JRNYS and FuturHealth offer. If the 2027-2028 compounded GLP-1 regulatory landscape consolidates further, Helimeds's branded Wegovy and Zepbound paths remain intact.

Helimeds GLP-1 side effects

Side effects are the same as any GLP-1 medication because the active ingredients are identical. Helimeds publishes a dedicated Important Safety Information page — editorially appropriate. Standard FDA-mandated safety considerations include:

• Boxed warning: Thyroid C-cell tumor risk; do not use if you or family member has history of medullary thyroid carcinoma (MTC) or MEN 2 syndrome.
• Serious side effects requiring monitoring: Acute pancreatitis, diabetic retinopathy complications, hypoglycemia, acute kidney injury, serious allergic reactions, acute gallbladder disease, increase in heart rate, suicidal behavior and ideation monitoring.
• Common side effects: Nausea, vomiting, diarrhea, stomach pain, constipation — particularly during titration weeks 1-4.

Who Helimeds is best for

Helimeds is a strong fit if you:

• Want a $37.25/week ($149/month) compounded tirzepatide entry tier — meaningful savings versus TrimRx ($259) or DirectMeds ($399) tirzepatide pricing
• Value full LegitScript approval with a verifiable seal (368688)
• Want parallel FDA-approved branded Wegovy and Zepbound on the same platform — strong hedge against compounded supply tightening
• Appreciate peer-reviewed evidence citation for marketing claims — Helimeds cites PMC11231910 for the 15.3% figure
• Want a broad adjacent product menu (sermorelin, NAD+, MIC+B12, sexual wellness) on one platform
• Are comfortable with text-only medical support (1-on-1 text, not phone or video)
• Appreciate operational transparency — Travex Inc parent disclosure, affiliate program disclosed

Helimeds is not the best fit if you:

• Need the absolute lowest published monthly cost ($89 at JRNYS or $99 at bmiMD)
• Require a named Chief Medical Officer publicly displayed (see Dr. Legere at JRNYS, Dr. Chopra at MyStart)
• Want a concrete money-back weight-loss guarantee (see sister brand Clinic Secret 6/12-month tiered)
• Want video or phone medical consultations rather than text-only
• Are pregnant, nursing, under 18, or have GLP-1 contraindications

Real-world Helimeds patient feedback

Helimeds displays verified-customer testimonials on its homepage covering both GLP-1 weight loss and adjacent products. Notable named testimonials include:

• Dawson Davila — Cites consistent weight loss progress (first month 10 lbs; ongoing ~1 lb/week) and improved satiety control.
• Rita Rigid — Reports loss of 42 lbs over 10 months (started at 190, now 148 on 1.5 mg dose) with restored exercise capacity after knee/hypertension issues.
• Marshall Barajas — Cites the telehealth consultation professionalism and personalized scheduling.
• Kristin Hester — Cites the convenience of telehealth + personalized approach + medical supervision confidence.
• Donald Ray — Cites the structured approach + door-delivery convenience + scheduling flexibility.

The named testimonials cover both early-program (1-3 month) and longer-term (10+ month) experiences — useful editorial signal that patients are retained through full titration cycles.

Helimeds combines a $37.25/week headline price on compounded GLP-1+GIP with full LegitScript approval, parallel FDA-approved branded Wegovy and Zepbound options, and one of the few published peer-reviewed source citations (PMC11231910) backing a marketing claim in our 14-platform 2026 review set.— Bartley Editorial Analysis

Helimeds vs alternatives

Helimeds's structural position: among the strongest combinations of published low headline tirzepatide pricing ($149/month equivalent), full LegitScript approval, FDA-approved branded medication backup (Wegovy, Zepbound), and peer-reviewed evidence citation in our 14-platform 2026 review set. JRNYS still edges Helimeds on price floor and named medical leadership, but Helimeds's $149 tirzepatide-equivalent specifically targets a value gap that most platforms don't address (most price tirzepatide at $250-$400 range).

Helimeds pros and cons

Helimeds sign-up & ongoing-care checklists

Helimeds frequently asked questions

Honest verdict — should you choose Helimeds?

Helimeds earns its 4.2/5 editor's rating on a structurally distinctive value combination: $37.25/week ($149/month) headline price on compounded GLP-1+GIP (tirzepatide), full LegitScript approval (verifiable seal 368688), parallel FDA-approved branded Wegovy and Zepbound paths on the same platform, and one of the few published peer-reviewed evidence citations (PMC11231910) we've encountered backing a marketing claim in our 14-platform 2026 review set. The compounded tirzepatide pricing specifically — at $149/month equivalent — addresses a real value gap, since most platforms price compounded tirzepatide meaningfully higher than compounded semaglutide (TrimRx $259, DirectMeds $399). The FDA-approved branded backup is the strongest available insurance against future compounded supply tightening. And the Travex Inc parent disclosure (sister brand to Clinic Secret) provides editorial transparency about the corporate structure that most platforms don't surface.

What pulls the rating below JRNYS's 4.6/5 ceiling is straightforward: $149/month is meaningfully above JRNYS's $89 and bmiMD's $99 published floor. A named Chief Medical Officer isn't publicly displayed (Helimeds-affiliated providers referenced as a group). The medical support is text-only — no phone or video consultations advertised. And specific compounding pharmacy partner names aren't publicly disclosed.

The bottom line

If you specifically want compounded tirzepatide at $149/month equivalent with FDA-approved branded Wegovy and Zepbound on the same platform, full LegitScript approval, and peer-reviewed evidence citation backing the marketing claim, Helimeds is one of the strongest options in our 14-platform 2026 review set. If you prioritize the absolute lowest published cost, JRNYS at $89 or bmiMD at $99 are objectively cheaper — but neither matches Helimeds's specific compounded-tirzepatide $149 tier. If you want the parent-group's other product, sister brand Clinic Secret trades the price advantage for a concrete 6/12-month money-back guarantee.

Published: June 3, 2026 · Last updated: June 3, 2026 · Verified: June 2026 · Spot a factual issue? Tell our editors.